Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 2, 2009, Pages 593-598

  Li, Yuhua ^a   Wang, Shifeng ^a   Scarpellini, Giorgio ^a   Gunn, Bronwyn ^a,b   Xin, Wei ^a   Wanda, Soo Young ^a   Roland, Kenneth L ^a   Curtiss III, Roy ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Bacterial vectors; Streptococcus pneumoniae

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIAL VECTOR; BACTERIUM ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 4; LIVE VACCINE; PNEUMOCOCCAL SURFACE PROTEIN A; SALMONELLOSIS VACCINE; UNCLASSIFIED DRUG;

ALPHA HELIX; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG SCREENING; EXPERIMENTAL MOUSE; FEMALE; GENE EXPRESSION; HOST; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; NONHUMAN; PHENOTYPE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROVOCATION TEST; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SEROTYPE; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE; SURVIVAL; T LYMPHOCYTE; VACCINATION; WILD TYPE;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; HEAT-SHOCK PROTEINS; IMMUNITY; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-4; MICE; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SALMONELLA VACCINES; T-LYMPHOCYTES; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

BACTERIA (MICROORGANISMS); MUS; SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; STREPTOCOCCUS PNEUMONIAE;

EID: 58849132311     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0811697106     Document Type: Article

References (34)

1. Kwon YM, Cox MM, Calhoun LN (2007) Salmonella-based vaccines for infectious diseases. Expert Rev Vaccines 6:147-152.
2. Medina E, Guzman CA (2001) Use of live bacterial vaccine vectors for antigen delivery: Potential and limitations. Vaccine 19:1573-1580.
3. Raupach B, Kaufmann SHE (2001) Bacterial virulence, proinflammatory cytokines and host immunity: How to choose the appropriate Salmonella vaccine strain? Microbes Infect 3:1261-1269.
4. Dunstan SJ, Simmons CP, Strugnell RA (1998) Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen. Infect Immun 66:732-740.
5. Garmory HS, et al. (2003) The use of live attenuated bacteria as a delivery system for heterologous antigens. J Drug Target 11:471-479.
6. Hohmann EL, Oletta CA, Miller SI (1996) Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers Vaccine 14:19-24.
7. Tacket CO, et al. (1997) Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the asd-balanced lethal vector system. Infect Immun 65:3381-3385.
8. Curtiss R, III, et al. (2007) in Virulence Mechanisms of Bacterial Pathogens, ed Brogden K, et al. (American Society for Microbiology Press, Washington, DC), pp 297-313.
9. Curtiss R, III, Wanda SY, Zhang X, Gunn B (2007) Salmonella vaccine vectors displaying regulated delayed in vivo attenuation to enhance immunogenicity, 107th General Meeting American Society for Microbiology, Toronto, Canada, p 278, abstr E-061.
10. Stocker BA, Wilkinson RG, Mäkelä PH (1966) Genetic aspects of biosynthesis and structure of Salmonella somatic polysaccharide. Ann N Y Acad Sci 133:334-348.
11. Collins LV, Attridge S, Hackett J (1991) Mutations at rfc or pmi attenuate Salmonella typhimurium virulence for mice. Infect Immun 59:1079-1085.
12. Guzman LM, Belin D, Carson MJ, Beckwith J (1995) Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol 177:4121-4130.
13. Garcia-del Portillo F, Foster JW, Finlay BB (1993) Role of acid tolerance response genes in Salmonella typhimurium virulence. Infect Immun 61:4489-4492.
14. Curtiss R, III, Kelly SM (1987) Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect Immun 55:3035-3043.
15. Katzman RL, Lisowska E, Jeanloz RW (1970) Invertebrate connective tissue. Isolation of D-arabinose from sponge acidic polysaccharide. Biochem J 119:17-19.
16. Curtiss R, III et al. (2009) Salmonella vaccine strains with regulated delayed attenuation in vivo. Infect Immun, in press.
17. Kang HY, Srinivasan J, Curtiss R, III (2002) Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine. Infect Immun 70:1739-1749.
18. Xin W, et al. (2008) Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis. Infect Immun 76:3241-3254.
19. DeKruyff RH, Rizzo LV, Umetsu DT (1993) Induction of immunoglobulin synthesis by CD4+ T cell clones. Semin Immunol 5:421-430.
20. Gor DO, Rose NR, Greenspan NS (2003) Th1-Th2:Aprocrustean paradigm. Nat Immunol 4:503-505.
21. Pashine A, et al. (1999) Th1 dominance in the immune response to live Salmonella typhimurium requires bacterial invasiveness but not persistence. Int Immunol 11:481-489.
22. Pascual DW, et al. (1999) Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response. Infect Immun 67:6249-6256.
23. Ramarathinam L, Niesel DW, Klimpel GR (1993) Salmonella typhimurium induces IFN-γ production in murine splenocytes. Role of natural killer cells and macrophages. J Immunol 150:3973-3981.
24. Link C, et al. (2006) An SopB-mediated immune escape mechanism of Salmonella enterica can be subverted to optimize the performance of live attenuated vaccine carrier strains. Microbes Infect 8:2262-2269.
25. Briles DE, et al. (1996) PspA, a protection-eliciting pneumococcal protein: Immunogenicity of isolated native PspA in mice. Vaccine 14:858-867.
26. Bertani G (1951) Studies on lysogenesis I: The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol 62:293-300.
27. Nakayama K, Kelly SM, Curtiss R, III (1988) Construction of an asd+ expression-cloning vector: Stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Nat Biotechnol 6:693-697.
28. Schwyn B, Neilands JB (1987) Universal chemical assay for the detection and determination of siderophores. Anal Biochem 160:47-56.
29. Hitchcock PJ, Brown TM (1983) Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J Bacteriol 154:269-277.
30. Konjufca V, Wanda S-Y, Jenkins MC, Curtiss R, III (2006) A recombinant attenuated Salmonella enterica serovar Typhimurium vaccine encoding Eimeria acervulina antigen offers protection against E. acervulina challenge. Infect Immun 74:6785-6796.
31. Nabors GS, et al. (2000) Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules. Vaccine 18:1743-1754.
32. Sedgwick JD, Holt PG (1983) A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J Immunol Methods 57:301-309.
33. Jonathan RK, et al. (2004) Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: Negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis. J Med Virol 74:147-155.
34. Nayak AR, et al. (1998)Alive recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae. Infect Immun 66:3744-3751.